Who
Elizabeth G. O'Farrell
Director
Company insider
Files Form 4 as: Director, Lensar; Director, Geron; Director, SpyGlass Pharma; Director, Inhibikase Therapeutics; Director, Pdl Biopharma.
In numbers
- Trades disclosed
- 37
- Buys
- 3
- Sells
- 2
- Bought
- $64K
- Sold
- $214K
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 22 Jun 2018
- Last trade
- 3 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 5 Jun 2026 | LNSR LensarMedical Devices | SEC FORM 4 Code A | —17,421 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | LNSR LensarMedical Devices | SEC FORM 4 Code A | —17,421 at $0.00 | filing |
| 20 May 2026filed 26 May 2026 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code A | —220,000 at $0.00 | filing |
| 20 May 2026filed 26 May 2026 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code A | —220,000 at $0.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code A | —13,700 at $0.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code A | —13,700 at $0.00 | filing |
| 23 May 2025filed 28 May 2025 | LNSR LensarMedical Devices | SEC FORM 4 Code A | —7,374 at $0.00 | filing |
| 21 May 2025filed 22 May 2025 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
| 9 May 2024filed 10 May 2024 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
| 7 May 2024filed 9 May 2024 | LNSR LensarMedical Devices | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 24 Aug 2023filed 24 Aug 2023 | GERN GeronBiotechnology | SEC FORM 4 Bought | $15K6,607 at $2.28 | filing |
| 24 Aug 2023filed 24 Aug 2023 | GERN GeronBiotechnology | SEC FORM 4 Bought | $15K6,579 at $2.28 | filing |
| 31 May 2023filed 2 Jun 2023 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 25 May 2023filed 30 May 2023 | LNSR Lensaroption or derivative · Medical Devices | SEC FORM 4 Code A | —33,175 at $0.00 | filing |
| 25 May 2023filed 30 May 2023 | LNSR LensarMedical Devices | SEC FORM 4 Code A | —9,288 at $0.00 | filing |
| 24 Jun 2022filed 28 Jun 2022 | IKT Inhibikase Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 25 May 2022filed 27 May 2022 | LNSR Lensaroption or derivative · Medical Devices | SEC FORM 4 Code A | —15,616 at $0.00 | filing |
| 25 May 2022filed 27 May 2022 | LNSR LensarMedical Devices | SEC FORM 4 Code A | —4,285 at $0.00 | filing |
| 10 May 2022filed 11 May 2022 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 25 Jun 2021filed 29 Jun 2021 | IKT Inhibikase Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,677 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.